WHITEPAPER - 3D SCREEN Printing: Enabling a New Generation of Complex Formulations
The pharmaceutical industry has been acquainted with the promise of 3D printing for some time now, with many large pharma companies exploring the possibilities of the technology. However, 3D-printed pharmaceuticals have been largely relegated to niche markets and prototyping due to limited scalability and reliance on manufacturing
processes that could potentially damage APIs.
But now a new technology, 3D screen printing, is shattering those constraints and opening new frontiers in drug formulation and manufacture.
Total Page Views: 416
